Sickle Cell Trait, Inequity, and the Need for Change

Because of misperceptions about risks, people with sickle cell trait (SCT) in the U.S. may receive inequitable and potentially harmful treatment, with implications for autonomy, privacy, and justice. This article calls out the discriminatory practices related to mandatory SCT testing by the NCAA and US military. SCT has also been used in troubling ways in forensic determination of cause of death and in managing stem cell transplant donors. Read more in this article published in NEJM, by BIDMC pathologist Richard Haspel, MD, and hematologist Brian Carney, MD.

Anemia | BIDMC of Boston can help diagnosis and treat SCT.